NI Technology Updates Outlooks for Cree, Microchip Technology, International Rectifier, OmniVision Technologies and Diodes Incorporated

Author
SySAdmin
Posted
March 2, 2010
Views
2239

Page All:

Page 1
NI Technology Updates Outlooks for Cree, Microchip Technology, International Rectifier, OmniVision Technologies and Diodes Incorporated

PRINCETON, N.J., March 2 -- Next Inning Technology Research (http://www.nextinning.com/), an online investment newsletter focused on semiconductor and technology stocks, announced it has updated outlooks for Cree (NASDAQ:CREE), Microchip Technology (NASDAQ:MCHP), International Rectifier (NYSE:IRF), OmniVision Technologies (NASDAQ:OVTI) and Diodes Incorporated (NASDAQ:DIOD).

Editor Paul McWilliams has displayed uncanny accuracy in identifying winners and losers during this challenging and historic period for the markets.  After logging a very successful 2009, McWilliams is now intently focused on the catalysts that will generate profits in 2010.

Most recently, McWilliams identified the timing of the market's latest dip and rebound for Next Inning readers in his quarterly Strategy Review. McWilliams has also just published a special report in the emerging and volatile solar energy sector that identifies the key drivers for the industry as well as likely winners and losers.  These reports, as well as McWilliams' regular commentary, are available for free to trial subscribers.

In addition, a Next Inning trial subscription also offers access to the "10 Tech Trends for 2010" special report, in which McWilliams lays out this year's key tech sector stories from cloud computing to virtualization to data centers and solid state drives, and McWilliams' highly acclaimed State of Tech reports that offer in-depth sector by sector coverage of over 65 leading tech companies and McWilliams' specific guidance on which stocks he thinks investors should own and which should be avoided.  Finally, subscribers will have access to McWilliams' daily commentary and actionable alerts that have been providing frequent profit opportunities for Next Inning subscribers for years.  To take advantage of this offer and receive these reports for free, please visit the following link:

https://www.nextinning.com/subscribe/index.php?refer=prn972

  McWilliams covers these topics and more in his recent reports:

-- McWilliams came about as close as he ever has to pounding the table for Cree when it dropped below $15 in late 2008.  With the stock now up nearly 400% from that entry point, does he think there is more to come or that it's time for investors to take profits?

-- McWilliams' detailed analysis of Cree helped his readers embrace the story there early.  Not only was he able to shed light on Cree's strategy, he has predicted Cree's forward earnings with uncanny accuracy.  McWilliams' early forecasts for fiscal 2009 were more than 50% above the then current consensus, but as it turned out, within a penny of what Cree eventually reported.  What is McWilliams predicting for fiscal 2010 and 2011 and how do those predictions match up against the estimates offered by Wall Street analysts?

-- Microchip has moved higher by 18% since McWilliams recommended it to investors in November.  Is he expecting further gains?  What does McWilliams think about the deal Microchip has struck to buy Silicon Storage Technology? What stock does McWilliams think investors should consider pairing with Microchip?

-- What does McWilliams see as the risks and the critical success factors facing International Rectifier that investors should monitor going forward?  What does he think about the forward earnings consensus for International Rectifier?  Does McWilliams think the stock merits holding at its current price?

-- In late 2008, McWilliams suggested that Next Inning readers buy OmniVision at its then current price in the mid-$5s.  His reasoning was that the strong balance sheet and a surge in smartphone demand during 2009 would lead to a possible triple.  Late last year, after OmniVision shares had tripled, he advised Next Inning subscribers to sell.  What, if anything, changed about the OmniVision story, and is it time for investors to consider OmniVision again?

-- In December 2008 McWilliams carefully explained to Next Inning readers why Wall Street was wrong to sell off Diodes Inc.  Not only were analysts wrong in their view of the temporary adjustments Diodes was forced to make to its balance sheet, but they were also wrong in how they viewed the aggregate demand for Diodes' products.  After outlining trades that yielded 500% gains for Next Inning subscribers, does McWilliams think Diodes is poised to reward investors further?

Founded in September 2002, Next Inning's model portfolio has returned 253% since its inception versus 24% for the S&P 500.

About Next Inning:

Next Inning is a subscription-based investment newsletter that provides regular coverage on more than 150 technology and semiconductor stocks.  Subscribers receive intra-day analysis, commentary and recommendations, as well as access to monthly semiconductor sales analysis, regular Special Reports, and the Next Inning model portfolio. Editor Paul McWilliams is a 30+ year semiconductor industry veteran.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926.  Interested parties may visit adviserinfo.sec.gov for additional information.  Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

CONTACT: Marcia Martin, Next Inning Technology Research, +1-888-278-5515

Source: Indie Research Advisors, LLC
   

CONTACT:  Marcia Martin, Next Inning Technology Research,
+1-888-278-5515

Web Site:  http://www.nextinning.com/

Title

Medium Image View Large